Epidemiology Non-cholera Vibrio Infections
INFECTIVE
Multicentre Retrospective Study on the Clinical and Epidemiological Characteristics and Therapeutic Management of Non-cholera Vibrio Infections
1 other identifier
observational
67
1 country
7
Brief Summary
The purpose of this study is to identify the epidemiological and clinical characteristics of patients diagnosed with non-cholera Vibrio infection in Western France from 2000 to 2019.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2020
Shorter than P25 for all trials
7 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 12, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 17, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 17, 2020
CompletedFirst Submitted
Initial submission to the registry
June 24, 2020
CompletedFirst Posted
Study publicly available on registry
June 30, 2020
CompletedResults Posted
Study results publicly available
March 15, 2021
CompletedOctober 31, 2023
October 1, 2023
3 months
June 24, 2020
February 19, 2021
October 26, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants With Diagnosed Non-cholerae or Non-O1/O139 Vibrio Infection
A non-cholerae or non-O1/O139 Vibrio infection was defined by a biological sample (blood, superficial sample, deep sample, and ear sample) positive to a Vibrio species other than Vibrio cholerae O1-O139.
Up to 20 years, from 2000-2019
Secondary Outcomes (6)
Number of Patients Per Clinical History
at inclusion
Number of Participants Associated With Environmental Factors
at inclusion
Number of Participants Per Identified Species
at inclusion
Number of Participants by Month of the Years
at inclusion
Number of Participants Treated by Antibiotics
through study completion, an average of 1 month
- +1 more secondary outcomes
Study Arms (1)
non-cholera Vibrio infection
Patients diagnosed with non-cholera Vibrio infection in Western France from 2000 to 2019
Interventions
Epidemiology of patients diagnosed with non-cholera Vibrio infection
Eligibility Criteria
Patients diagnosed with non-cholera Vibrio infection in Western France from 2000 to 2019
You may qualify if:
- non-cholera Vibrio infection
You may not qualify if:
- vibriosis to Vibrio cholerae O1 and O139
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (7)
CHU Angers
Angers, France
CHU Bordeaux
Bordeaux, France
Centre Hospitalier Départemental de la Vendée
La Roche-sur-Yon, France
CHU Nantes
Nantes, France
CHU Poitiers
Poitiers, France
CHU Rennes
Rennes, France
CHU Tours
Tours, France
Related Publications (5)
Weis KE, Hammond RM, Hutchinson R, Blackmore CG. Vibrio illness in Florida, 1998-2007. Epidemiol Infect. 2011 Apr;139(4):591-8. doi: 10.1017/S0950268810001354. Epub 2010 Jun 14.
PMID: 20546636BACKGROUNDMorris JG Jr. Cholera and other types of vibriosis: a story of human pandemics and oysters on the half shell. Clin Infect Dis. 2003 Jul 15;37(2):272-80. doi: 10.1086/375600. Epub 2003 Jul 3.
PMID: 12856219BACKGROUNDGivens CE, Bowers JC, DePaola A, Hollibaugh JT, Jones JL. Occurrence and distribution of Vibrio vulnificus and Vibrio parahaemolyticus--potential roles for fish, oyster, sediment and water. Lett Appl Microbiol. 2014 Jun;58(6):503-10. doi: 10.1111/lam.12226. Epub 2014 Feb 27.
PMID: 24571291BACKGROUNDJones MK, Oliver JD. Vibrio vulnificus: disease and pathogenesis. Infect Immun. 2009 May;77(5):1723-33. doi: 10.1128/IAI.01046-08. Epub 2009 Mar 2. No abstract available.
PMID: 19255188BACKGROUNDHoefler F, Pouget-Abadie X, Roncato-Saberan M, Lemarie R, Takoudju EM, Raffi F, Corvec S, Le Bras M, Cazanave C, Lehours P, Guimard T, Allix-Beguec C. Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001-2019. Emerg Infect Dis. 2022 Dec;28(12):2367-73. doi: 10.3201/eid2812.220748.
PMID: 36418019RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr Florence Hoefler
- Organization
- Groupe Hospitalier La Rochelle Ré Aunis
Study Officials
- STUDY DIRECTOR
Florence Hoefler, MD
Groupe Hospitalier de la Rochelle Ré Aunis
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 24, 2020
First Posted
June 30, 2020
Study Start
March 12, 2020
Primary Completion
June 17, 2020
Study Completion
June 17, 2020
Last Updated
October 31, 2023
Results First Posted
March 15, 2021
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- CSR
- Time Frame
- From publication and up to 15 years after publication
- Access Criteria
- Contact the corresponding author of the publication
Data will be made available with publication. Keyword are infection, non-cholera Vibrio, epidemiology The only available version will be the locked database. The database will be made available by the study director upon request up to 15 years after publication. Medical Subject Headings (MESH) terms will be used to describe clinical data. Methodology for will be provided in the publication. International standard unit will be used.